1 withdrawn. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow AIDS: new trials by email Literature Review of AIDS trials Research Report on AIDS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| N-803 Combined With the Broadly Neutralizing Antibodies Plus or Minus haNK Cells for HIV N-803 and bNAbs, haNK™ Cells - Hiv, HIV/AIDS | Phase 1 / Phase 2 | Withdrawn | University of Minnesota | 2020-01-01 | 2020-10-22 |
Acquired Immunodeficiency Syndrome (1) · HIV Infections (1) · Infections (1)
Blood-Borne Infections (1) · Communicable Diseases (1) · Genital Diseases (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Lentivirus Infections (1) · RNA Virus Infections (1) · Retroviridae Infections (1) · Sexually Transmitted Diseases (1) · Sexually Transmitted Diseases, Viral (1) · Slow Virus Diseases (1) · Urogenital Diseases (1) · Virus Diseases (1)
ALT-803 (1) · Broadly Neutralizing Antibodies (1)
United States (1)